2005P-0411 | Seeking FDA Actions to Counter Flagrant Violations of the Law by Pharmacies Compounding Bio-Identical Hormone Replacement Therapy Drugs | |||||||||||||||||||||||
FDA Comment Number : | EC7118 | |||||||||||||||||||||||
Submitter : | Mrs. Debra Gibson | Date & Time: | 03/06/2006 10:03:36 | |||||||||||||||||||||
Organization : | Mrs. Debra Gibson | |||||||||||||||||||||||
Category : | Individual Consumer | |||||||||||||||||||||||
Issue Areas/Comments | ||||||||||||||||||||||||
GENERAL | ||||||||||||||||||||||||
GENERAL | ||||||||||||||||||||||||
I am concerned that Wyeth?s petition (Docket # 2005P-0411) would limit the ability of my physician and pharmacist to keep prescribing and preparing these individualized doses for me.
I have been using this product for approximately three years now. Following analysis of the data collected from my bloodwork, my physican prescribed BHRT to alleviate my symptoms, according to my own personal needs. I prefer this product over other estrogen supplements I have tried in the past. I believe that I should be able to continue to exercise my right to choose medications. Therefore, it is my opinion that the FDA should reject Wyeth?s petition. Debra Gibson | ||||||||||||||||||||||||